Supportive Care for Patients Newly Diagnosed With Lung Cancer
The aims of this project are to assess the feasibility of recruiting patients and delivering a nurse-led telephone based palliative care intervention for patients with newly diagnosed lung cancer and to assess if among patients with newly diagnosed lung cancer, the investigators can estimate the effect of a nurse-led telephone based palliative care intervention on quality-of-life, symptom burden and patient satisfaction.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Jan 31, 2017 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- VA Office of Research and Development
- Interventions being studied
- Behavioral: Palliative Care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Patients diagnosed at the Puget Sound Health Care System with a primary diagnosis of lung cancer,
- any cell type or stage,
- diagnosed within 8 weeks of study enrollment.
- Must have telephone access,
- ability of understand English and
- provide informed consent.
- Patients not eligible to participate in the study include those who are inpatients prior to randomization,
- those who are under the care of palliative care or hospice at the time of randomization,
- those who have severe mental health disorders,
- those who are unable to speak directly with the nurse over the telephone,
- or those that have the inability to provide informed consent. Investigators will recruit individuals (n=40) with lung cancer over a 12 month period.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- VA Puget Sound Health Care System Seattle Division, Seattle, WASeattle, Washington
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 31, 2017. Always confirm current availability with the study team.